如果这个靶点在更多人身上...查看全文
智通财经APP获悉,生物技术公司Immutep(IMMP.US)宣布已经与默沙东(MRK.US)下属子公司达成临床试验合作协议。Immutep将开展名为TACTI-003的2b期临床试验,检验其主打候选疗法eftilagimod alpha(又名efti或IMP321)与默沙东公司的PD-1抑制... 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-155363 Act: 34 Size: 35 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-153648 Act: 34 Size: 54 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-139703 Act: 34 Size: 50 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-129562 Act: 34 Size: 50 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-123571 Act: 34 Size: 129 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-110465 Act: 34 Size: 43 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-101096 Act: 34 Size: 37 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-051615 Act: 34 Size: 506 KB 网页链接
$Immutep(IMMP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000318989-24-000077 Act: 34 Size: 9 KB 网页链接
$Immutep(IMMP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-019399 Act: 34 Size: 148 KB 网页链接